Stocks 27 May 2026 - 2 June 2026

Liquidia Sinks 5% After Recent Rally

Liquidia Sinks 5% After Recent Rally

Liquidia Corporation shares were flat in early trading Tuesday after falling hard the day before. Investors are watching for more news from the company on YUTREPIA, its inhaled drug for lung disease. The Nasdaq stock ended Monday at $58.75, off 5.04%, and was last seen at $58.91 in thin premarket action at 6:22 a.m. EDT, according to MarketWatch. Liquidia has been a top biotech pick for 2026, with the stock gaining about 70% year to date through Monday, Yahoo Finance data show. Shares touched an intraday high of $63.46 last week before pulling back.
June 2, 2026
GIBO Stock Moves Before The Bell — The Tiny Volume Behind The AI Microcap’s Bounce

GIBO Stock Moves Before The Bell — The Tiny Volume Behind The AI Microcap’s Bounce

GIBO Holdings shares were indicated higher in thin premarket trading on Tuesday, clawing back part of Monday’s decline before the regular Nasdaq session opened. ADVFN showed the stock at $1.34 at 6:03 a.m. EDT, up 3.1% from a $1.30 close, on just 725 shares — volume, meaning the number of shares traded, too light to call a firm trend. That matters now because the move comes in the premarket session, the trading window before Nasdaq’s 9:30 a.m. open, when small stocks can move sharply on limited orders. Nasdaq lists regular trading from 9:30 a.m. to 4:00 p.m. Eastern time and its 2026 holiday calendar does not show a June 2 closure.
June 2, 2026
Capricor Shares Fall, FDA Call in August Looms

Capricor Shares Fall, FDA Call in August Looms

Capricor Therapeutics shares moved lower in early trading Tuesday, following a 4.8% decline in the regular session. The rare-disease biotech is trading near $28.53 before the bell, as the stock stays focused on its looming U.S. regulatory date, not the broader market rally. Capricor’s current market value stands at around $1.64 billion. Capricor isn’t trading like a typical small-cap biotech anymore. Its valuation is tied to deramiocel, its experimental cell therapy for Duchenne muscular dystrophy, and the decision from the U.S. Food and Drug Administration, due by Aug. 22.
June 2, 2026
indie Semiconductor Stock Drops After Hours as Filings Raise New Questions for INDI Investors

indie Semiconductor Stock Drops After Hours as Filings Raise New Questions for INDI Investors

indie Semiconductor shares slipped in late Monday trading, lagging a firmer Nasdaq-linked tape, as investors weighed fresh compensation filings and an insider-sale report rather than a new operating update from the automotive-chip supplier. The stock was last at $4.87, down about 2.1%, after trading between $4.83 and $5.13 on volume of 4.45 million shares. The move matters now because the latest disclosures touch share count and insider selling, two pressure points for a small chip company still working toward steady profitability. For holders, the question is not just whether indie can sell more sensor chips into cars and industrial machines, but how much equity it may need to issue along the way.
June 2, 2026
Pulmatrix Stock Slides As Eos Merger Clock Starts To Matter For PULM Holders

Pulmatrix Stock Slides As Eos Merger Clock Starts To Matter For PULM Holders

Pulmatrix Inc shares slipped in thin early Nasdaq trading on Monday, with the stock again moving around the planned merger with Eos SENOLYTIX rather than a fresh drug-data catalyst. The stock was quoted at $1.37, down 1.44%, at 09:30:01 a.m. ET, with volume of about 1,010 shares against a three-month average of roughly 50,490. Investing.com listed the company’s market value at about $5 million and its 52-week range at $1.16 to $9.23. The Nasdaq Composite was down 0.15% in the same market snapshot, while the S&P 500 was off 0.09%.
June 1, 2026
Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute Shares Edge Higher Ahead of Key FDA Week

Rezolute Inc. shares ticked up in premarket trading Monday, with the gain coming ahead of a scheduled appearance by company executives at a healthcare event later this week. The shares were at $3.30, up 4 cents, with the rare-disease drug maker’s market cap around $343 million. This was before the regular Nasdaq open; the exchange lists pre-market hours from 4:00 a.m. to 9:30 a.m. Eastern.
June 1, 2026
Gentherm Faces Pivotal Week After Shares Rebound 6%

Gentherm Faces Pivotal Week After Shares Rebound 6%

Gentherm Inc. starts Monday’s Nasdaq session with a short-term gain at stake, after it finished Friday at $34.69, up nearly 6% in the last five days. Still, the stock is off 4.62% for the year. Regular Nasdaq hours begin at 9:30 a.m. Eastern, with pre-market trading available from 4 a.m. to the open. The timing is key with the story now shifting from a quarterly update to a test on deals and margins. Gentherm will meet investors at Stifel on Tuesday, then CEO Bill Presley and CFO Jon Douyard head to a Baird fireside chat in New York on Wednesday. That puts the Modine deal, tariff expenses, and 2026 outlook in the spotlight again for shareholders.
June 1, 2026
Baldwin Insurance Shares Dip as Wall Street Hits Record Highs

Baldwin Insurance Shares Dip as Wall Street Hits Record Highs

Baldwin Insurance Group shares fell in the last trading session before the weekend, ending the holiday-shortened week down as the insurer lagged a U.S. equity market that kept hitting new records. Baldwin shares ended Friday at $19.42, slipping 44 cents, or 2.2%. Volume was about 2.0 million. Over the week, with U.S. markets shut Monday for Memorial Day, the stock dropped from $19.66 at last Wednesday’s close, off around 1.2%.
June 1, 2026
EGH Stock Drifts Near $10.35 as Hecate Deal Deadline Looms

EGH Stock Drifts Near $10.35 as Hecate Deal Deadline Looms

EGH Acquisition Corp. finished the holiday-shortened week nearly flat, closing Friday at $10.35. Investors stayed on the sidelines, watching for the next merger filing with Hecate Energy Group. The stock edged up 0.2% from its $10.33 close on May 22. In that time, the Nasdaq-100 gained about 2.9%. U.S. equity markets were closed Monday for Memorial Day, so the Nasdaq’s 2026 calendar showed four regular trading days left before the weekend.
May 30, 2026
Manhattan Associates Stock Jumped Before the Weekend. A Quick Test Looms

Manhattan Associates Stock Jumped Before the Weekend. A Quick Test Looms

Manhattan Associates Inc. climbed 4.8% Friday, finishing at $150.05. The stock is now up about 8.2% from last Friday’s close. U.S. markets were closed Monday for Memorial Day, with Nasdaq listing May 25 as a holiday. MANH reopened Tuesday and ran higher into the end of the week. Stocks rose with the market this week, not alone. The S&P 500 logged its ninth week higher, and the Nasdaq Composite was up 2.4% for the week, according to AP. That momentum helped growth-software stocks stay firm in June.
May 30, 2026
Polyrizon Shares Flat After Delay in New Filing Near Highs

Polyrizon Shares Flat After Delay in New Filing Near Highs

Polyrizon Ltd. ended Thursday mostly flat as the Israel-based biotech named a new board member. The update didn’t include trial results or financing. Shares last traded at $16.50, up a penny. During the session, the price moved between $17.165 and $16.17. Polyrizon is a micro-cap, with shares changing hands near the stock's 52-week high. The company has a market value around $29.5 million, according to Robinhood, with volume at 76,000 shares, higher than the 35,650 average. Its 52-week range is $2.88 to $18.20.
May 28, 2026
POLE Stock Is Quiet. Andretti Acquisition II’s September Deadline Is Not

POLE Stock Is Quiet. Andretti Acquisition II’s September Deadline Is Not

Andretti Acquisition Corp. II’s Nasdaq-listed Class A shares, POLE, last stood at $10.71 on Thursday, down 0.3%, with just 3,504 shares reported traded and a market value of about $316 million. The tape was thin. The clock was not. Thursday was a normal U.S. equity session, not a holiday-shortened market day. Nasdaq lists regular stock-market hours at 9:30 a.m. to 4:00 p.m. ET, and its 2026 holiday calendar shows Memorial Day was May 25, with the next U.S. market closure on June 19 for Juneteenth.
May 28, 2026
Aldel Financial II Stock Barely Moves, But Its SPAC Clock Is Ticking

Aldel Financial II Stock Barely Moves, But Its SPAC Clock Is Ticking

Aldel Financial II Inc. shares were little changed on Thursday, quoted at $10.66, up one cent, as the blank-check company’s stock stayed pinned near the cash value backing its public shares. Trading was thin, with market data showing an intraday volume of 82 shares and no meaningful price range. That matters now because Aldel is a SPAC, or special purpose acquisition company — a shell that raises cash in public markets to merge with a private business. It is not trading like a bank, broker or asset manager with operating earnings; it is trading like a vehicle still waiting for a deal.
May 28, 2026
Relay Therapeutics Shares Reclaim Offer Price as Traders Eye June

Relay Therapeutics Shares Reclaim Offer Price as Traders Eye June

Relay Therapeutics traded up on Thursday, staying above last week’s public offer price. Some investors moved past dilution concerns and turned attention to two June investor events, with management expected to field questions about lead asset zovegalisib. Shares were at $14.50 as of 11:46 a.m. EDT, up roughly 0.5%. The SPDR S&P Biotech ETF was also up 0.6%, and the iShares Nasdaq Biotechnology ETF added 0.9%. Relay is moving fast. The company said Wednesday that management will appear at the Jefferies Global Healthcare Conference on June 3 and the Goldman Sachs Global Healthcare Conference on June 8. Those showings come less than two weeks after Relay ran a stock sale and dropped new clinical data in its rare-disease program.
May 28, 2026
Radware Drops 3% After Shareholder Vote

Radware Drops 3% After Shareholder Vote

Radware Ltd. shares are down 3% heading into Thursday's Nasdaq open, as investors look at a routine shareholder vote and fresh numbers on the Israeli security firm's cloud business. Radware said Wednesday its shareholders passed all three proposals at the annual meeting. Timing is key here. The Nasdaq hadn’t begun its normal trading day in New York at that time. Regular hours are 9:30 a.m. to 4:00 p.m. Eastern, and pre-market kicks off at 4:00 a.m. May 28 doesn’t show up as a market holiday; Memorial Day was May 25, and Juneteenth is June 19.
May 28, 2026
Imunon Shares Trade Early After CEO Gets Stock Grant

Imunon Shares Trade Early After CEO Gets Stock Grant

Imunon Inc shares looked set to open up premarket Thursday. The thinly traded stock ticked higher after a Wednesday evening filing revealed CEO Stacy Lindborg took stock rather than a portion of her salary. The Nasdaq-listed biotech changed hands at $2.38 in pre-market trade at 7:30 a.m. ET, a gain of 3.5% from the previous close. Just 531 shares had traded, based on Public.com. Pre-market action often swings more because there aren’t as many participants trading before the regular session.
May 28, 2026
Atlas Lithium Stock Near $4 Before Shareholder Vote: Why ATLX Traders Are Watching Today

Atlas Lithium Stock Near $4 Before Shareholder Vote: Why ATLX Traders Are Watching Today

Atlas Lithium Corp. shares were steady in early U.S. trading on Thursday, with the lithium developer heading into its annual meeting as investors weighed governance votes against the slower, harder question: whether its Neves project in Brazil can move from contractors and equipment into production. The Nasdaq-listed stock closed Wednesday at $4.15, down 1.19%, and was shown at $4.16 in extended trading at 6:56 a.m. ET, according to MarketBeat. Nasdaq’s regular session opens at 9:30 a.m. ET, with premarket trading available from 4:00 a.m. ET.
May 28, 2026
IPCX Stock Holds Around $10.31 Ahead of A1R WATER Deal Test

IPCX Stock Holds Around $10.31 Ahead of A1R WATER Deal Test

Inflection Point Acquisition Corp. III stayed steady premarket on the Nasdaq Thursday, trading unchanged at $10.31. Investors are waiting for an update on the SPAC’s planned deal with A1R WATER as the merger move heads to a vote. IPCX last showed a 0.1% gain from the prior close. The company’s market cap was around $355.4 million, according to the latest data. Nasdaq trades from 9:30 a.m. to 4 p.m. Eastern time. May 28 is a regular day on the 2026 schedule. Memorial Day fell on Monday, May 25. IPCX is open for trading during a standard Thursday, but SPAC names sometimes see light liquidity early.
May 28, 2026
Arcadia Biosciences Stock Under $1: Why RKDA’s Next Move Hinges on Zola and Cash

Arcadia Biosciences Stock Under $1: Why RKDA’s Next Move Hinges on Zola and Cash

Arcadia Biosciences Inc. shares were quoted higher but still below $1 early Thursday, leaving the micro-cap wellness-products company in a narrow market lane where small changes in cash, sales or financing can move the stock. Micro-cap means a company with a very small market value; Arcadia’s was about $1.9 million at the latest quote. Why it matters now: there was no newer operating release on Arcadia’s investor-relations feed after its May 14 results, and the latest listed company filing was May 15. That puts the focus back on what the last filing cycle showed — Zola coconut water growth on one side, funding pressure on the other.
May 28, 2026
Goldman issues warning on CooperCompanies ahead of earnings

Goldman issues warning on CooperCompanies ahead of earnings

CooperCompanies traded 0.4% higher early on Nasdaq Wednesday at $62.28 after Goldman Sachs lowered its price target to $61 from $69, sticking with a Sell. That values the San Ramon, Calif. medical device company at $12.24 billion. The timing is key. Cooper’s fiscal Q2 results hit in less than two weeks, due June 4 after the bell, with the earnings call scheduled for 5 p.m. ET. There’s not much new company news for investors right now, so the Goldman action puts a pre-earnings flag in the stock.
May 27, 2026
1 2 3 9